111 related articles for article (PubMed ID: 33128955)
21. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
[TBL] [Abstract][Full Text] [Related]
22. Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome.
Helle OMB; Pedersen TH; Ousager LB; Thomassen M; Hertz JM
Mol Genet Genomic Med; 2020 Oct; 8(10):e1452. PubMed ID: 32812400
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical and molecular genetic evidence for type IV collagen alpha5 chain abnormality in the anterior lenticonus associated with Alport syndrome.
Ohkubo S; Takeda H; Higashide T; Ito M; Sakurai M; Shirao Y; Yanagida T; Oda Y; Sado Y
Arch Ophthalmol; 2003 Jun; 121(6):846-50. PubMed ID: 12796257
[TBL] [Abstract][Full Text] [Related]
24. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.
Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L
Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316
[TBL] [Abstract][Full Text] [Related]
25.
Zhang P; Zhuo L; Zou Y; Li G; Peng K
Clin Nephrol; 2019 Aug; 92(2):98-102. PubMed ID: 31198170
[No Abstract] [Full Text] [Related]
26. COL4A5-associated X-linked Alport syndrome in a female patient with early inner ear deafness due to a mutation in MYH9.
Strasser K; Hoefele J; Bergmann C; Büscher AK; Büscher R; Hoyer PF; Weber S
Nephrol Dial Transplant; 2012 Nov; 27(11):4236-40. PubMed ID: 23144074
[TBL] [Abstract][Full Text] [Related]
27. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
[TBL] [Abstract][Full Text] [Related]
28. Linkage analysis and a novel COL4A5 mutation in a large Turkish family with Alport syndrome.
Tug E; Percin FE; Pala E; Baysoy G
Genet Couns; 2011; 22(2):143-53. PubMed ID: 21848006
[TBL] [Abstract][Full Text] [Related]
29. A family case of X-linked Alport syndrome patients with a novel variant in COL4A5.
Kashiwagi Y; Suzuki S; Agata K; Morishima Y; Inagaki N; Numabe H; Kawashima H
CEN Case Rep; 2019 May; 8(2):75-78. PubMed ID: 30293132
[TBL] [Abstract][Full Text] [Related]
30. Generation of induced pluripotent stem cell line (ZZUi0024-A) from a 51-year-old patient with APP gene mutation in Alzheimer' s disease.
Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Wang Y; Xu Y
Stem Cell Res; 2021 May; 53():102267. PubMed ID: 33652304
[TBL] [Abstract][Full Text] [Related]
31. [Detection of a novel mutation in COL4A5 gene from a Chinese family with X-linked alport syndrome].
Peng CL; Liang H; Z ou QL; Wang J; Liu CS; Zhang XF; Chen J; Hu SN
Yi Chuan Xue Bao; 2004 Nov; 31(11):1190-5. PubMed ID: 15651669
[TBL] [Abstract][Full Text] [Related]
32. The Alport syndrome COL4A5 variant database.
Crockett DK; Pont-Kingdon G; Gedge F; Sumner K; Seamons R; Lyon E
Hum Mutat; 2010 Aug; 31(8):E1652-7. PubMed ID: 20574986
[TBL] [Abstract][Full Text] [Related]
33. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
[TBL] [Abstract][Full Text] [Related]
34. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
35. Gene symbol: COl4A5. Disease: Alport Syndrome.
Savige J
Hum Genet; 2008 Oct; 124(3):302. PubMed ID: 18846628
[No Abstract] [Full Text] [Related]
36. Reassessing the pathogenicity of c.2858G>T(p.(G953V)) in COL4A5 Gene: report of 19 Chinese families.
Zhang Y; Ding J; Wang S; Zhang H; Zhong X; Liu X; Xu K; Wang F
Eur J Hum Genet; 2020 Feb; 28(2):244-252. PubMed ID: 31576025
[TBL] [Abstract][Full Text] [Related]
37. Gene symbol: COL4A5. Disease: Alport Syndrome.
Savige J; Tan R; Colville D; Wang Y; Parkin JD; Mathew N; Savige J
Hum Genet; 2008 Oct; 124(3):301. PubMed ID: 18846626
[No Abstract] [Full Text] [Related]
38. Generation of induced pluripotent stem cell line (ZZUi0016-A) from dermal fibroblasts of a normal human.
Gao Y; Wang Y; Wang Z; Sun H; Zhang R; Yang J; Liu Y; Liu H; Zhang Q; Zhang S; Shi C; Xu Y; Song B
Stem Cell Res; 2020 Mar; 43():101717. PubMed ID: 32007761
[TBL] [Abstract][Full Text] [Related]
39. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts.
Wang F; Wang Y; Ding J; Yang J
Kidney Int; 2005 Apr; 67(4):1268-74. PubMed ID: 15780079
[TBL] [Abstract][Full Text] [Related]
40. Improved genetic counseling in Alport syndrome by new variants of COL4A5 gene.
Fernandez-Rosado F; Campos A; Alvarez-Cubero MJ; Ruiz A; Entrala-Bernal C
Nephrology (Carlton); 2015 Jul; 20(7):502-5. PubMed ID: 26063487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
